TITLE:
      Efficacy Assessment of Systematic Treatment With Folinic Acid and Thyroid Hormone on Psychomotor Development of Down Syndrome Young Children
SUMMARY:
      Evaluation of the following in very young children with Down syndrome:

        -  the efficacy of systematic treatment with L-thyroxine at controlled doses (clinically
           and by ultrasensitive thyreostimulating hormone (TSH) assay),

        -  the efficacy of systematic folinic acid treatment at a dose of 1 mg/kg/o.i.d,

        -  any interaction between these two treatments.
ELIGIBILITY CRITERIA:
      Inclusion Criteria:

          -  patient with a karyotype demonstrating homogeneous, free or Robertsonian
             translocation trisomy 21

          -  patient having undergone a cardiac ultrasound not demonstrating any severe heart
             disease

          -  patient aged 6 to 18 months at inclusion

        Exclusion Criteria:

          -  congenital hypothyroidism

          -  hypothyroidism demonstrated by laboratory tests

          -  presenting or having presented hyperthyroidism

          -  presenting or having presented leukaemia

          -  presenting or having presented West syndrome or any other form of epilepsy or
             unstable neurological disease

          -  presenting or having presented signs of central nervous system distress: stroke,
             postoperative hypoxia, meningitis)

          -  presenting severe heart disease on cardiac ultrasound, with haemodynamic effects

          -  presenting non-controlled cardiac arrhythmia

          -  Apgar < 7 to 5 min at birth

          -  Gestational age < 245 days (35 weeks)
